by Maria Zannes | Jun 6, 2023 | Events
bioAffinity Technologies, Inc. held its 2023 Annual Meeting of Stockholders on June 6, 2023, both in person at the Company’s principal office in San Antonio, TX, and virtually via a live webcast on June 6, 2023. Shareholders were entitled to cast one vote per share of...
by Maria Zannes | May 22, 2023 | Press Releases
SAN ANTONIO, Texas (May 22, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today will present the poster “Development of...
by Maria Zannes | May 15, 2023 | Press Releases
SAN ANTONIO, Texas (May 15, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three...
by Maria Zannes | May 8, 2023 | Articles, News
bioAffinity Technologies CEO Maria Zannes says the company has made a key hire May 4, 2023 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. has made a key change in its...
by Maria Zannes | May 1, 2023 | Press Releases
SAN ANTONIO, Texas (May 1, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael Dougherty has joined the company...
